Benitec Biopharma (BNTC) Return on Equity (2020 - 2025)
Historic Return on Equity for Benitec Biopharma (BNTC) over the last 6 years, with Q1 2025 value amounting to 0.11%.
- Benitec Biopharma's Return on Equity rose 14800.0% to 0.11% in Q1 2025 from the same period last year, while for Mar 2025 it was 0.11%, marking a year-over-year increase of 14800.0%. This contributed to the annual value of 0.91% for FY2024, which is 114900.0% up from last year.
- Latest data reveals that Benitec Biopharma reported Return on Equity of 0.11% as of Q1 2025, which was up 14800.0% from 0.14% recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Return on Equity registered a high of 0.11% during Q1 2025, and its lowest value of 7.78% during Q2 2023.
- Its 5-year average for Return on Equity is 1.73%, with a median of 1.32% in 2021.
- Per our database at Business Quant, Benitec Biopharma's Return on Equity tumbled by -43400bps in 2023 and then surged by 70400bps in 2024.
- Benitec Biopharma's Return on Equity (Quarter) stood at 1.32% in 2021, then fell by -19bps to 1.56% in 2022, then increased by 26bps to 1.15% in 2023, then surged by 88bps to 0.14% in 2024, then grew by 17bps to 0.11% in 2025.
- Its Return on Equity stands at 0.11% for Q1 2025, versus 0.14% for Q4 2024 and 0.38% for Q3 2024.